期刊文献+

斑块状银屑病外周血单一核细胞p16基因甲基化状态的研究 被引量:4

Study on Methylation Status of pl6 Gene in PBMC of Patients with Plaque Psoriasis
原文传递
导出
摘要 目的探讨银屑病患者外周血单一核细胞p16基因甲基化状态。方法采用甲基化特异的聚合酶链反应对34例斑块状银屑病患者和35例正常人外周血单一核细胞p16基因甲基化状态进行分析,银屑病的严重程度按PASI评分评估。结果斑块状银屑病外周血单一核细胞p16基因甲基化率高于正常人,差异有统计学意义(P<0.05),但单一核细胞p16基因甲基化状态对疾病的严重程度和病程无明显影响(P>0.05)。结论斑块状银屑病外周血单一核细胞p16基因甲基化率明显增高,在银屑病的发病机制中可能起某些作用。 Objective To study the methylation status of p16 gene in peripheral blood mononuclear cell (PBMC) of patients with plaque psoriasis, and to study its significance in the pathogenesis of the disease. Methods Thirty-four cases of psoriatic patients and 35 healthy controls were measured for the status of promoter methylation in p16 gene by methylation specific PCR (MSP). A region containing CpG site in p16 gene promoter was amplified by MSP. The severity of psoriasis was evaluated by PASI scores. Results The methylation rates of p16 gene in PBMC were significantly higher (P〈0.05) in psoriatic patients than those in the controls, but it was unrelated to the severity and course of the disease. Conclusions Higher rates of hyperrne-thylation of p16 gene are found in PBMC of the patients with plaque psoriasis, suggesting that p16 gene hypermethylation of PBMC may be involved in the pathogenesis of psoriasis.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2005年第9期578-580,共3页 Chinese Journal of Dermatology
  • 相关文献

参考文献7

  • 1Ortonne JP. Aetiology and pathogenesis of psoriasis. Br J Dermatol,1996, 135 Suppl 49: 1-5.
  • 2郑敏,浙江大学医学院第二医院皮肤科.银屑病是细胞免疫介导性疾病?[J].中华皮肤科杂志,2002,35(2):85-87. 被引量:90
  • 3Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res, 1995, 55: 4525-4530.
  • 4Pilon C, Pistorello M, Moscon A, et al. Inactivation of the p16 tumor suppressor gene in adrenocortical tumors. J Clin Endocrinol Metab,1999, 84: 2776-2779.
  • 5张长宋,赵天恩,陈树民.银屑病病情严重程度评判指标的研究现状[J].国外医学(皮肤性病学分册),2002,28(2):82-84. 被引量:71
  • 6Herman JG, Graff JR, MyohAnen S, et al. Methylation-specific PCR:A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA, 1996, 93:9821-9826
  • 7陆前进,卢放根,颜兰香,文海泉,张其亮,张桂英,余桂英,杨竹林.银屑病患者皮损中CDK_4和p16蛋白表达[J].中华皮肤科杂志,1998,31(2):104-105. 被引量:10

二级参考文献26

  • 1Kondo S, Yoneta A, Yazawa H, et al. Downregulation of CXCR- 2 but not CXCR- 1 expression by human keratinocytes by UVB. J Cell Physiol, 2000,182:366- 370.
  • 2Vandenbark AA, Morgan E, Bartholomew R, et al. TCR peptide therapy in human autoimmune diseases. Neurochem Res, 2001,26:713- 730.
  • 3Raychaudhuri SP, Farber EM. Neuroimmunologic aspects of psoriasis. Cutis, 2000,66:357- 362.
  • 4Schroder JM, Harder J. Human beta- defensin- 2. Int J Biochem Cell Biol, 1999,31:645- 651.
  • 5Nickoloff BJ. Creation of psoriatic plaques: the ultimate tumor suppressor pathway. A new model for an ancient T- cell- mediated skin disease. Viewpoint. J Cutan Pathol, 2001,28:57- 64.
  • 6Hwang ST. Mechanisms of T cell homing to skin. Adv Dermatol, 2001,17:211- 241.
  • 7Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol, 2002,46:1- 23.
  • 8Aruffo A, Hollenbaugh D. Therapeutic intervention with inhibitors of co- stimulatory pathways in autoimmune disease. Curr Opin Immunol, 2001,13:683- 686.
  • 9van de Kerkhof PC. The Psoriasis Area and Severity Index and altermative approaches for the assessment of severity: persisting areas of confusion. Br J Dermatol, 1997,137(4):661-662.
  • 10Harari M, Shani J, Hristakieva E, et al. Clinical evaluation of a more repid and sensitive Psoriasis Assessment Severity Score (PASS), and its comparison with the classic method of Psoriasis Area and Severity Index (PASI), before and after climatotherapy at the Dead-Sea, Int J Dermatol, 2000,39(12) :913-918.

共引文献165

同被引文献29

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部